IO Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IO Biotech and other ETFs, options, and stocks.About IOBT
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms.
CEOMai-Britt Zocca
CEOMai-Britt Zocca
Employees80
Employees80
HeadquartersCopenhagen, North Denmark
HeadquartersCopenhagen, North Denmark
Founded2014
Founded2014
Employees80
Employees80
IOBT Key Statistics
Market cap49.47M
Market cap49.47M
Price-Earnings ratio-0.51
Price-Earnings ratio-0.51
Dividend yield—
Dividend yield—
Average volume808.54K
Average volume808.54K
High today$0.7239
High today$0.7239
Low today$0.6491
Low today$0.6491
Open price$0.6689
Open price$0.6689
Volume1.02M
Volume1.02M
52 Week high$2.79
52 Week high$2.79
52 Week low$0.3234
52 Week low$0.3234
Stock Snapshot
IO Biotech(IOBT) stock is priced at $0.70, giving the company a market capitalization of 49.47M. It carries a P/E multiple of -0.51.
During the trading session on 2025-12-05, IO Biotech(IOBT) shares reached a daily high of $0.72 and a low of $0.65. At a current price of $0.70, the stock is +7.8% higher than the low and still -3.3% under the high.
Trading activity shows a volume of 1.02M, compared to an average daily volume of 808.54K.
Over the past 52 weeks, IO Biotech(IOBT) stock has traded between a high of $2.79 and a low of $0.32.
Over the past 52 weeks, IO Biotech(IOBT) stock has traded between a high of $2.79 and a low of $0.32.
Analyst ratings
67%
of 6 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
People also own
Based on the portfolios of people who own IOBT. This list is generated using Robinhood data, and it’s not a recommendation.